Company: ZLAB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038548
Chunk: 62

Company: Zai Lab Ltd
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 62
---
$Net cash used in operating activities(92,723)(132,279)39,556 Net cash provided by investing activities323,211 2,446 320,765 Net cash provided by financing activities51,990 69,870 (17,880)Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash125 (137)262 Net increase (decrease) in cash, cash equivalents and restricted cash282,603 (60,100)342,703 

Net Cash Used in Operating Activities 

Net cash used in operating activities decreased by $39.6 million in the six months ended June 30, 2025, primarily due to a decrease of $44.6 million in net loss and an increase of $11.5 million in net changes in operating assets and liabilities, partially offset by a decrease of $16.5 million in other adjustments to reconcile net loss to net cash used in operating activities.

Net Cash Provided by Investing Activities 

Net cash provided by investing activities increased by $320.8 million in the six months ended June 30, 2025, primarily due to an increase of $313.7 million in proceeds from the maturity of short-term investments, a decrease of $8.5 million from acquisitions of intangible assets, and an increase of $1.2 million in proceeds from the sale of our equity investment in MacroGenics, partially offset by an increase of $2.7 million in purchases of property and equipment.

Net Cash Provided by Financing Activities 

Net cash provided by financing activities decreased by $17.9 million in the six months ended June 30, 2025, primarily due to $82.8 million in repayment of short-term bank borrowings and $0.9 million in payments of public offering costs, partially offset by an increase of $54.4 million in short-term debt proceeds and an increase of $11.4 million in proceeds from exercises of stock options.

27

Recently Issued Accounting Standards 

For more information regarding recently issued accounting standards, see Part II – Item 8. Financial Statements and Supplementary Data – Recent Accounting Pronouncements in our 2024 Annual Report. The Company has not adopted any new accounting standards in the three and six months ended June 30, 2025.

Item 3. Quantitative and Qualitative Disclosures About Market Risk 

We are exposed to market risk including foreign exchange risk, credit risk, and interest rate risk. 

Foreign Exchange Risk 

Renminbi,